A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy
Ontology highlight
ABSTRACT: A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy
PROVIDER: PRJNA543423 | ENA |
REPOSITORIES: ENA
ACCESS DATA